INS and Hypoglycemia: Detemir insulin in comparison to NPH: The outcomes obtained after treatment with detemir or NPH insulins reveal the identical extent of HbA1c/FPS (fasting plasma sugar) [80,81,82,83,84], since detemir is correlated with the lesser possibility of hypoglycemia [81,83,84,85,86], and involving in night-time hypoglycemic evidence [80,81,82,84,85,86,87].